(Q30856653)

English

Correlation of three immunohistochemically detected markers of neuroendocrine differentiation with clinical predictors of disease progression in prostate cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

Correlation of three immunohistochemically detected markers of neuroendocrine differentiation with clinical predictors of disease progression in prostate cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

immunohistochemistry

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

author name string

Farhat Abbas

2

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

Nuzhat Faruqui

3

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

Mohammad Israr

4

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

Shahid Pervez

5

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

30 December 2008

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

8

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

21

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

copyright license

Creative Commons Attribution 2.0 Generic

1 December 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Cancer statistics, 2007

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628675

28 July 2018

Expression of pS2 in prostate cancer correlates with grade and Chromogranin A expression but not with stage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628675

28 July 2018

Practical markers used in the diagnosis of endocrine tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628675

28 July 2018

Prostate cancer: are new prognostic markers on the horizon?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628675

28 July 2018

Neuroendocrine carcinomas of the prostate and urinary bladder: a diagnostic and therapeutic challenge

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628675

28 July 2018

A.P.U.D. type endocrine tumour of the prostate. Incidence and prognosis in association with adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628675

28 July 2018

Neuro-endocrine cells--a new prognostic parameter in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628675

28 July 2018

Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628675

28 July 2018

Detection of prostate cancer and predicting progression: current and future diagnostic markers

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-8-21

21 January 2018

Practical markers used in the diagnosis of neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-8-21

21 January 2018

Prognostic significance of plasma chromogranin a levels in patients with hormone-refractory prostate cancer treated in Cancer and Leukemia Group B 9480 study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-8-21

21 January 2018

Divergent neuroendocrine differentiation in prostatic carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628675

25 November 2018

Prognostic significance of neuroendocrine differentiation in clinically localized prostatic carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628675

25 November 2018

Neuroendocrine differentiation in prostatic intraepithelial neoplasia and adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19115997

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroendocrine differentiation in stage D2 prostate cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/19115997

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pretreatment serum level of neuron specific enolase (NSE) as a prognostic factor in metastatic prostate cancer patients treated with endocrine therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19115997

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chromogranin a concentration as a serum marker to predict prognosis after endocrine therapy for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19115997

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic influence of neuroendocrine cells in prostate cancer: Results of a long-term follow-up study with patients treated by radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19115997

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Precursors of prostatic cancer: progression, regression and chemoprevention

1 reference

https://pubmed.ncbi.nlm.nih.gov/19115997

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2490-8-21

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30856653&oldid=2195021375"